Long-term follow-up of postbariatric surgery mortality rates: a meta-analysis
In brief
Sleeve surgery linked to 0.76% seven-year mortality, versus 2.64% without surgery
In a meta-analysis of 34 studies and nearly 450,000 people, pooled seven-year mortality was 0.76% after sleeve surgery and 2.64% among nonsurgical controls; mortality was also lower after gastric bypass at seven and 12 years. These observational comparisons show a durable association, not proof of cause, and deaths from accidents, substance abuse and suicide made up a higher share after bypass.
- Journal
- Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (Q1)
- Published
- 14 October 2026
- Study design
- Systematic review of cohort studies
- Evidence level
- Level 2, Moderate (CEBM 2a)
- Authors
- Kai He, Marcus H Cunningham, Iwanger-I-Ter T Jia, Grace C Bloomfield, Mike Y Chen, Annie Wang, et al.
- PMID
- 43026104
- DOI
- 10.1016/j.soard.2026.10.009
Why clinicians should know about it
- Picked for Bariatric and Metabolic Surgery (paper of the day, 15 November 2026): Long-term comparative mortality after sleeve and gastric bypass
Abstract
BACKGROUND: Bariatric surgery effectively treats obesity and related co-morbidities, but the magnitude and durability of long-term mortality benefit compared with nonsurgical management remain poorly characterized. OBJECTIVES: To synthesize the longest-term available mortality data comparing bariatric surgery with nonsurgical weight management in patients with obesity. SETTING: Large-scale meta-analysis. METHODS: A meta-analysis was conducted of studies published between 2000 and 2025 reporting mortality outcomes after sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB) compared with control cohorts with obesity. Survival at all available postoperative intervals was evaluated. Mixed-effects meta-regression assessed patient-specific modifiers of mortality, whereas random-effects meta-analyses evaluated timepoint-specific mortality and cause-of-death differences. RESULTS: Thirty-four studies including 449,957 patients were analyzed. Early postoperative mortality was low across all cohorts. Over a longer follow-up, bariatric surgery was associated with lower cumulative mortality compared with nonsurgical controls. At 7 years, pooled mortality was 2.64% in controls, 1.64% following RYGB, and .76% following sleeve gastrectomy. At 12 years, mortality remained lower after RYGB (4.34%) compared with controls (7.11%). Among patients with type 2 diabetes, mortality at 5 years was substantially lower following RYGB compared with diabetic controls (2.29% versus 11.0%). Cause-of-death analysis demonstrated fewer cancer-related deaths after RYGB (odds ratio, .46; 95% confidence interval, .31-.70) but higher proportions of deaths due to accidents, substance abuse, and suicide. CONCLUSIONS: Bariatric surgery is associated with durable reductions in long-term mortality compared with nonsurgical management of obesity, particularly among patients with type 2 diabetes, supporting its role as an important intervention for improving long-term survival in severe obesity.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.